Robust Nanoparticle Morphology and Size Analysis by Atomic Force Microscopy for Standardization.


Journal

Chemical & pharmaceutical bulletin
ISSN: 1347-5223
Titre abrégé: Chem Pharm Bull (Tokyo)
Pays: Japan
ID NLM: 0377775

Informations de publication

Date de publication:
2020
Historique:
entrez: 4 8 2020
pubmed: 4 8 2020
medline: 5 2 2021
Statut: ppublish

Résumé

Because of the complexity of nanomedicines, analysis of their morphology and size has attracted considerable attention both from researchers and regulatory agencies. The atomic force microscope (AFM) has emerged as a powerful tool because it can provide detailed morphological characteristics of nanoparticles both in the air and in aqueous medium. However, to our knowledge, AFM methods for nanomedicines have yet to be standardized or be listed in any pharmacopeias. To assess the applicability of standardization of AFM, in this study, we aimed to identify robust conditions for assessing the morphology and size of nanoparticles based on a polystyrene nanoparticle certified reference material standard. The spring constant of the cantilever did not affect the size of the nanoparticles but needed to be optimized depending on the measurement conditions. The size analysis method of the obtained images affected the results of the analyzed size values. The results analyzed by cross-sectional line profiling were independent of the measurement conditions and gave similar results to those from dynamic light scattering. It was indicated that approximately 100 particles are required for a representative measurement. Under the optimized conditions, there were no significant inter-instrument differences in the analyzed size values of polystyrene nanoparticles both in air and under aqueous conditions.

Identifiants

pubmed: 32741922
doi: 10.1248/cpb.c20-00311
doi:

Substances chimiques

Polystyrenes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

791-796

Auteurs

Kumiko Sakai-Kato (K)

Kitasato University.

Yuki Takechi-Haraya (Y)

Division of Drugs, National Institute of Health Sciences.

Tsukasa Chida (T)

Kowa Company, Ltd., Fuji Research Laboratories.

Manami Okazaki (M)

Nippon Kayaku Co., Ltd., Pharmaceuticals Research Laboratories.

Masato Kozaki (M)

Kowa Company, Ltd., Fuji Research Laboratories.

Articles similaires

Humans Middle Aged Female Male Surveys and Questionnaires
Adolescent Child Female Humans Male
Humans Scoliosis Mobile Applications Retrospective Studies Artificial Intelligence

Classifications MeSH